PhagePro

About:

PhagePro is an early-stage biotechnology therapeutics company.

Website: https://www.phageproinc.com/

Top Investors: National Institutes of Health, Massachusetts Life Sciences Center, MassVentures

Description:

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable communities.

Total Funding Amount:

$3.19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)phageproinc.com

Founders:

Andrew Camilli, Minimin Yen

Number of Employees:

1-10

Last Funding Date:

2024-05-22

IPO Status:

Private

Industries: